QPHARMA

QPHARMA has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €2,500 and a net result of €53,114. Equity is shrinking by about 48% per year and would, assuming unchanged policy, indicatively turn negative around fiscal year 2026. Its solvency ranks better than 10% of 38,960 sector peers (NACE 70, fiscal year 2025). The computed 12-month bankruptcy probability is 0.4% (very low).